Compare O'will Corp. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 6,001 Million (Micro Cap)
7.00
NA
0.00%
0.43
17.70%
1.01
Revenue and Profits:
Net Sales:
9,563 Million
(Quarterly Results - Mar 2026)
Net Profit:
-59 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-62.47%
0%
-62.47%
6 Months
-62.64%
0%
-62.64%
1 Year
-57.23%
0%
-57.23%
2 Years
-41.68%
0%
-41.68%
3 Years
-37.73%
0%
-37.73%
4 Years
-34.93%
0%
-34.93%
5 Years
-33.46%
0%
-33.46%
O'will Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.79%
EBIT Growth (5y)
26.02%
EBIT to Interest (avg)
74.41
Debt to EBITDA (avg)
0.65
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
4.01
Tax Ratio
30.80%
Dividend Payout Ratio
19.62%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.66%
ROE (avg)
15.05%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
1.20
EV to EBIT
6.52
EV to EBITDA
5.90
EV to Capital Employed
1.14
EV to Sales
0.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.51%
ROE (Latest)
17.70%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
9,563.20
10,739.20
-10.95%
Operating Profit (PBDIT) excl Other Income
-25.30
403.90
-106.26%
Interest
22.70
18.90
20.11%
Exceptional Items
-60.00
0.00
Consolidate Net Profit
-58.70
231.70
-125.33%
Operating Profit Margin (Excl OI)
-6.90%
35.10%
-4.20%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -10.95% vs -1.59% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -125.33% vs -6.04% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
41,909.20
39,156.00
7.03%
Operating Profit (PBDIT) excl Other Income
1,500.50
1,255.80
19.49%
Interest
72.70
44.90
61.92%
Exceptional Items
-87.20
0.00
Consolidate Net Profit
802.50
916.40
-12.43%
Operating Profit Margin (Excl OI)
32.70%
29.70%
0.30%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 7.03% vs 23.23% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is -12.43% vs 31.67% in Mar 2025
About O'will Corp. 
O'will Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






